CLINICAL_TRIALS
trial_result
· 2009-03-12
Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression [Phase 3]
Summary
A Phase 3 trial completed evaluating the efficacy and safety of SR58611A in elderly patients with depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED